Circadian disruption is increasingly recognized as a cardiovascular risk factor, but its impact on the microvascular architecture of the eye has received far less attention. The retina offers a rare window into systemic vascular health — its vessels mirror what is happening in coronary and cerebral circulation — making any signal here potentially meaningful for broad cardiovascular surveillance.

Drawing on over 12.6 million commercially insured adults aged 18–64 enrolled in the Merative MarketScan database between 2012 and 2014, this nationwide cohort study examined new diagnoses of four retinal vascular conditions — retinal artery occlusion (RAO), retinal vein occlusion (RVO), proliferative diabetic retinopathy (PDR), and neovascular age-related macular degeneration (nvAMD) — in the week and month following each daylight saving time (DST) transition. Compared with a summer control period, the spring transition was associated with a 34% higher hazard of PDR (aHR 1.34, 98.75% CI 1.19–1.50) and a 24% higher hazard of nvAMD (aHR 1.24, 1.03–1.50) within the following month. The autumn transition, by contrast, was associated with modestly lower risk of RVO and PDR relative to the summer control, suggesting the direction of circadian disruption matters — losing an hour of sleep appears more physiologically destabilizing than gaining one.

This study's scale is its primary strength, but several limitations temper interpretation. The observational design cannot establish causation; seasonal confounders such as ambient temperature, activity levels, and UV exposure are difficult to fully disentangle from the clock-change effect itself. The cohort is restricted to working-age commercially insured adults, limiting generalizability to older or uninsured populations — precisely the groups at highest baseline risk for these conditions. The biological mechanism most likely involves cortisol dysregulation, heightened sympathetic tone, and platelet aggregability changes that follow acute sleep loss, all of which can promote thrombotic and angiogenic activity in already-compromised retinal vasculature. Incremental rather than paradigm-shifting, this work nonetheless reinforces the case for treating DST transitions as a genuine, if underappreciated, transient cardiovascular stressor.